Matthew Tripod, Kendra Mendez, Matthew Berger, Claire Shaffer, Timothy Yeung, Thomas G Costantino, Steven Peterson, Ryan C Gibbons
{"title":"U-POCUS方案:尿液分析和即时超声排除急诊科患者的症状性输尿管结石。","authors":"Matthew Tripod, Kendra Mendez, Matthew Berger, Claire Shaffer, Timothy Yeung, Thomas G Costantino, Steven Peterson, Ryan C Gibbons","doi":"10.1007/s43678-025-00998-z","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Urolithiasis is a common urological condition accounting for more than 1.3 million emergency department visits annually with costs exceeding $2.8 billion (Scales et al. in Eur Urol. 62:160-5, 2012;Eaton et al. in J Endourol 27:1535-1538, 2013;Antonelli et al. in Eur Urol 66:724-729, 2014;). Non-contrast computed tomography of the abdomen and pelvis remains the diagnostic gold standard. Studies assessing urinalysis and renal point-of-care ultrasound (PoCUS), individually, to diagnose symptomatic ureterolithiasis demonstrate inadequate sensitivities (Mefford et al. in West J Emerg Med 18:775, 2017;Eray et al. in Am J Emerg Med 21:152-4, 2003;Luchs et al. in Urology 59:839-842, 2002;Smith-Bindman et al. in N Engl J Med 371:1100-1110, 2014;Riddell et al. in West J Emerg Med 15:96-100, 2014;Rosen et al. in J Emerg Med 16:865-870, 1998;Gaspari and Horst in Acad Emerg Med 12:1180-1184, 2005;Watkins et al. in Emerg Med Australas 19:188-195, 2007;). The primary objective of this study was to assess the test characteristics of the U-PoCUS (urinalysis with renal point-of-care ultrasound) protocol.</p><p><strong>Methods: </strong>This was an Institutional Review Board approved, multi-center, retrospective chart review at a university-based healthcare system. Study investigators included all patients who presented from January 1, 2016 through June 30, 2020, and underwent computed tomography of the abdomen and pelvis and had a urinalysis and PoCUS for suspected ureterolithiasis. Investigators utilized MedCalc (Version 19.1.6) and standard 2 × 2 tables to calculate test characteristics with 95% confidence intervals (CI).</p><p><strong>Results: </strong>Study investigators enrolled 183 patients, including 122 patients diagnosed with computed tomography confirmed ureterolithiasis and 61 patients without it. The combination of hematuria and/or hydronephrosis on PoCUS had a sensitivity of 99.2% (95.6-100) and a specificity of 14.8% (7-26.2) for the presence of urolithiasis. Positive predictive value and negative predictive value were 69.9% (67.7-72.1) and 90% (53.9-98.6), respectively.</p><p><strong>Conclusion: </strong>The presence of hematuria and/or hydronephrosis was 99.2% sensitive for the presence of ureterolithiasis diagnosed on computed tomography of the abdomen and pelvis. The U-PoCUS protocol missed only one symptomatic ureterolithiasis.</p>","PeriodicalId":93937,"journal":{"name":"CJEM","volume":" ","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2025-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The U-POCUS protocol: urinalysis and point-of-care ultrasound to exclude symptomatic ureterolithiasis in emergency department patients.\",\"authors\":\"Matthew Tripod, Kendra Mendez, Matthew Berger, Claire Shaffer, Timothy Yeung, Thomas G Costantino, Steven Peterson, Ryan C Gibbons\",\"doi\":\"10.1007/s43678-025-00998-z\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>Urolithiasis is a common urological condition accounting for more than 1.3 million emergency department visits annually with costs exceeding $2.8 billion (Scales et al. in Eur Urol. 62:160-5, 2012;Eaton et al. in J Endourol 27:1535-1538, 2013;Antonelli et al. in Eur Urol 66:724-729, 2014;). Non-contrast computed tomography of the abdomen and pelvis remains the diagnostic gold standard. Studies assessing urinalysis and renal point-of-care ultrasound (PoCUS), individually, to diagnose symptomatic ureterolithiasis demonstrate inadequate sensitivities (Mefford et al. in West J Emerg Med 18:775, 2017;Eray et al. in Am J Emerg Med 21:152-4, 2003;Luchs et al. in Urology 59:839-842, 2002;Smith-Bindman et al. in N Engl J Med 371:1100-1110, 2014;Riddell et al. in West J Emerg Med 15:96-100, 2014;Rosen et al. in J Emerg Med 16:865-870, 1998;Gaspari and Horst in Acad Emerg Med 12:1180-1184, 2005;Watkins et al. in Emerg Med Australas 19:188-195, 2007;). The primary objective of this study was to assess the test characteristics of the U-PoCUS (urinalysis with renal point-of-care ultrasound) protocol.</p><p><strong>Methods: </strong>This was an Institutional Review Board approved, multi-center, retrospective chart review at a university-based healthcare system. Study investigators included all patients who presented from January 1, 2016 through June 30, 2020, and underwent computed tomography of the abdomen and pelvis and had a urinalysis and PoCUS for suspected ureterolithiasis. Investigators utilized MedCalc (Version 19.1.6) and standard 2 × 2 tables to calculate test characteristics with 95% confidence intervals (CI).</p><p><strong>Results: </strong>Study investigators enrolled 183 patients, including 122 patients diagnosed with computed tomography confirmed ureterolithiasis and 61 patients without it. The combination of hematuria and/or hydronephrosis on PoCUS had a sensitivity of 99.2% (95.6-100) and a specificity of 14.8% (7-26.2) for the presence of urolithiasis. Positive predictive value and negative predictive value were 69.9% (67.7-72.1) and 90% (53.9-98.6), respectively.</p><p><strong>Conclusion: </strong>The presence of hematuria and/or hydronephrosis was 99.2% sensitive for the presence of ureterolithiasis diagnosed on computed tomography of the abdomen and pelvis. The U-PoCUS protocol missed only one symptomatic ureterolithiasis.</p>\",\"PeriodicalId\":93937,\"journal\":{\"name\":\"CJEM\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2025-09-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"CJEM\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s43678-025-00998-z\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"CJEM","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s43678-025-00998-z","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
目的:尿石症是一种常见的泌尿系统疾病,每年急诊人数超过130万,费用超过28亿美元(Scales et al. in Eur Urol. 62:160- 5,2012;Eaton et al. in J Endourol . 27:1535-1538, 2013;Antonelli et al. in Eur Urol. 66:724-729, 2014;)。腹部和骨盆的非对比计算机断层扫描仍然是诊断的金标准。单独评估尿液分析和肾点护理超声(PoCUS)诊断症状性输尿管结石的敏感性不足(Mefford et al. in West J Emerg Med 18:775, 2017;Eray et al. in Am J Emerg Med 21:152- 4,2003;Luchs et al. in泌尿外科59:839-842,2002;中国生物医学工程学报(英文版);2005;Watkins et al. in emerging Med Australas 19:188- 195,2007;)。本研究的主要目的是评估U-PoCUS(肾脏即时超声尿液分析)方案的测试特征。方法:这是一项机构审查委员会批准的、多中心的、以大学为基础的医疗保健系统的回顾性图表审查。研究人员纳入了2016年1月1日至2020年6月30日期间就诊的所有患者,并对腹部和骨盆进行了计算机断层扫描,并对疑似输尿管结石进行了尿液分析和PoCUS。研究者使用MedCalc (Version 19.1.6)和标准的2 × 2表格计算具有95%置信区间(CI)的试验特征。结果:研究人员纳入183例患者,其中122例经计算机断层扫描确诊为输尿管结石,61例未确诊为输尿管结石。PoCUS合并血尿和/或肾积水对尿石症的敏感性为99.2%(96.6 -100),特异性为14.8%(7-26.2)。阳性预测值为69.9%(67.7-72.1),阴性预测值为90%(53.9-98.6)。结论:血尿和/或肾积水对腹部和骨盆ct诊断输尿管结石的敏感性为99.2%。U-PoCUS方案仅遗漏1例症状性输尿管结石。
The U-POCUS protocol: urinalysis and point-of-care ultrasound to exclude symptomatic ureterolithiasis in emergency department patients.
Objective: Urolithiasis is a common urological condition accounting for more than 1.3 million emergency department visits annually with costs exceeding $2.8 billion (Scales et al. in Eur Urol. 62:160-5, 2012;Eaton et al. in J Endourol 27:1535-1538, 2013;Antonelli et al. in Eur Urol 66:724-729, 2014;). Non-contrast computed tomography of the abdomen and pelvis remains the diagnostic gold standard. Studies assessing urinalysis and renal point-of-care ultrasound (PoCUS), individually, to diagnose symptomatic ureterolithiasis demonstrate inadequate sensitivities (Mefford et al. in West J Emerg Med 18:775, 2017;Eray et al. in Am J Emerg Med 21:152-4, 2003;Luchs et al. in Urology 59:839-842, 2002;Smith-Bindman et al. in N Engl J Med 371:1100-1110, 2014;Riddell et al. in West J Emerg Med 15:96-100, 2014;Rosen et al. in J Emerg Med 16:865-870, 1998;Gaspari and Horst in Acad Emerg Med 12:1180-1184, 2005;Watkins et al. in Emerg Med Australas 19:188-195, 2007;). The primary objective of this study was to assess the test characteristics of the U-PoCUS (urinalysis with renal point-of-care ultrasound) protocol.
Methods: This was an Institutional Review Board approved, multi-center, retrospective chart review at a university-based healthcare system. Study investigators included all patients who presented from January 1, 2016 through June 30, 2020, and underwent computed tomography of the abdomen and pelvis and had a urinalysis and PoCUS for suspected ureterolithiasis. Investigators utilized MedCalc (Version 19.1.6) and standard 2 × 2 tables to calculate test characteristics with 95% confidence intervals (CI).
Results: Study investigators enrolled 183 patients, including 122 patients diagnosed with computed tomography confirmed ureterolithiasis and 61 patients without it. The combination of hematuria and/or hydronephrosis on PoCUS had a sensitivity of 99.2% (95.6-100) and a specificity of 14.8% (7-26.2) for the presence of urolithiasis. Positive predictive value and negative predictive value were 69.9% (67.7-72.1) and 90% (53.9-98.6), respectively.
Conclusion: The presence of hematuria and/or hydronephrosis was 99.2% sensitive for the presence of ureterolithiasis diagnosed on computed tomography of the abdomen and pelvis. The U-PoCUS protocol missed only one symptomatic ureterolithiasis.